Yukai He

4.5k total citations · 1 hit paper
68 papers, 3.5k citations indexed

About

Yukai He is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yukai He has authored 68 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 25 papers in Oncology and 21 papers in Molecular Biology. Recurrent topics in Yukai He's work include Immunotherapy and Immune Responses (32 papers), CAR-T cell therapy research (19 papers) and Immune Cell Function and Interaction (14 papers). Yukai He is often cited by papers focused on Immunotherapy and Immune Responses (32 papers), CAR-T cell therapy research (19 papers) and Immune Cell Function and Interaction (14 papers). Yukai He collaborates with scholars based in United States, China and Georgia. Yukai He's co-authors include Louis D. Falo, Leaf Huang, David H. Munn, Stephanie D. Drenning, Zong Sheng Guo, David L. Bartlett, Jiying Zhang, Andrew L. Mellor, Madhav Sharma and Zuqiang Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Yukai He

66 papers receiving 3.5k citations

Hit Papers

Constitutive activation of Stat3 signaling abrogates apop... 2000 2026 2008 2017 2000 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesisin vivo
    2000 509 citations Simon C. Watkins, Yukai He et al. profile →

Peers

Yukai He
Asís Palazón Spain
Kazunori Aoki Japan
Scott Lonning United States
Shigeo Takaishi Japan
Jianxun Song United States
Mariëlle van Gijn Netherlands
Segundo González Spain
Frédérique Ponchel United Kingdom
Frank Leithäuser Germany
Mark P. Rubinstein United States
Asís Palazón Spain
Yukai He
Citations per year, relative to Yukai He Yukai He (= 1×) peers Asís Palazón

Countries citing papers authored by Yukai He

Since Specialization
Citations

This map shows the geographic impact of Yukai He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yukai He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yukai He more than expected).

Fields of papers citing papers by Yukai He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yukai He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yukai He. The network helps show where Yukai He may publish in the future.

Co-authorship network of co-authors of Yukai He

This figure shows the co-authorship network connecting the top 25 collaborators of Yukai He. A scholar is included among the top collaborators of Yukai He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yukai He. Yukai He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yang, et al.. (2025). Clinical Value of APRI and FIB-4 on Bleeding Risk and 30-Day Prognosis in Patients with Liver Cirrhosis Complicated with Esophagogastric Varices. International Journal of General Medicine. Volume 18. 6153–6167.
2.
Lv, Lin, Yukai He, Xunying Wang, et al.. (2025). Artificial oxyanion reservoir accelerates oriented ionic migration in MXene-based synaptic memristor for neuromorphic computing. Surfaces and Interfaces. 63. 106315–106315.
3.
Lu, Xinjun, Shanshan Deng, Benjamin L. Green, et al.. (2023). Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models. Journal of Clinical Investigation. 133(11). 27 indexed citations
4.
Mao, Rui, Mohamed S. Hussein, & Yukai He. (2022). Chimeric antigen receptor engineered T cells and their application in the immunotherapy of solid tumours. Expert Reviews in Molecular Medicine. 24. e7–e7. 14 indexed citations
5.
Mao, Rui, et al.. (2022). The affinity of antigen-binding domain on the antitumor efficacy of CAR T cells: Moderate is better. Frontiers in Immunology. 13. 1032403–1032403. 54 indexed citations
6.
Galva, Leidy D. Caraballo, Xiaotao Jiang, Mohamed S. Hussein, et al.. (2021). Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology. 76(2). 330–344. 17 indexed citations
7.
Tian, Han, Rong Lian, Yun Li, et al.. (2020). AKT-induced lncRNA VAL promotes EMT-independent metastasis through diminishing Trim16-dependent Vimentin degradation. Nature Communications. 11(1). 5127–5127. 98 indexed citations
8.
Cai, Lun, Leidy D. Caraballo Galva, Yibing Peng, et al.. (2020). Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells. Frontiers in Immunology. 11. 607–607. 20 indexed citations
9.
Luo, Xiaobing, Huijuan Cui, Lun Cai, et al.. (2020). Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit. Frontiers in Immunology. 11. 623–623. 27 indexed citations
10.
Wu, Sha, Wei Zhu, Yibing Peng, et al.. (2017). The Antitumor Effects of Vaccine-Activated CD8+ T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T Cells. Cancer Immunology Research. 5(10). 908–919. 23 indexed citations
11.
Cai, Junchao, Lishan Fang, Yongbo Huang, et al.. (2017). Simultaneous overactivation of Wnt/β-catenin and TGFβ signalling by miR-128-3p confers chemoresistance-associated metastasis in NSCLC. Nature Communications. 8(1). 15870–15870. 148 indexed citations
12.
Cui, Xia, et al.. (2016). miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL. Molecular and Cellular Biochemistry. 424(1-2). 195–201. 9 indexed citations
13.
Bartlett, David L., Zuqiang Liu, Magesh Sathaiah, et al.. (2013). Oncolytic viruses as therapeutic cancer vaccines. Molecular Cancer. 12(1). 103–103. 249 indexed citations
14.
He, Yukai, Yanjun Liu, Yibing Peng, & David H. Munn. (2009). Lentivector immunization stimulates potent CD8 T cell responses against melanoma self antigen tyrosinase related protein 1 and generates antitumor immunity in mice (41.10). The Journal of Immunology. 182(Supplement_1). 41.10–41.10. 1 indexed citations
15.
16.
17.
Ju, Songguang, Yibei Zhu, Lin Liu, et al.. (2009). Gadd45b and Gadd45g are important for anti‐tumor immune responses. European Journal of Immunology. 39(11). 3010–3018. 54 indexed citations
18.
Nayak, Jayakar V., David A. Hokey, Adriana T. Larregina, et al.. (2006). Phagocytosis Induces Lysosome Remodeling and Regulated Presentation of Particulate Antigens by Activated Dendritic Cells. The Journal of Immunology. 177(12). 8493–8503. 18 indexed citations
19.
He, Yukai, Jiying Zhang, Zhibao Mi, Paul D. Robbins, & Louis D. Falo. (2005). Immunization with Lentiviral Vector-Transduced Dendritic Cells Induces Strong and Long-Lasting T Cell Responses and Therapeutic Immunity. The Journal of Immunology. 174(6). 3808–3817. 122 indexed citations
20.
Mi, Michael, Jiying Zhang, & Yukai He. (2005). Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein. Retrovirology. 2(1). 71–71. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Asís Palazón Breakdown of academic impact, for papers by Kazunori Aoki Breakdown of academic impact, for papers by Scott Lonning Breakdown of academic impact, for papers by Shigeo Takaishi Breakdown of academic impact, for papers by Jianxun Song Breakdown of academic impact, for papers by Mariëlle van Gijn Breakdown of academic impact, for papers by Segundo González Breakdown of academic impact, for papers by Frédérique Ponchel Breakdown of academic impact, for papers by Frank Leithäuser Breakdown of academic impact, for papers by Mark P. Rubinstein
Rankless by CCL
2026